Ruben Mesa, MD, FACP1, Srdan Verstovsek, MD, PhD2, Uwe Platzbecker, MD3*, Vikas Gupta, MD, FRCP, FRCPath4, David Lavie, MD5*, Pilar Giraldo, PhD6, Jean-Jacques Kiladjian, MD7, Stephen T Oh, MD, PhD8, Timothy Devos, MD, PhD9, Francesco Passamonti, MD10*, Miklos Egyed, MD, PhD11*, Alessandro Vannucchi, MD12, Andrzej Pluta, MD13*, Donal P McLornan, MD, MRCP, PhD, FRCPath14*, Jun Kawashima, MD15*, Mei Huang, MS15*, Bryan Strouse, MSc15* and Claire N. Harrison, DM16
1Mays Cancer Center at UT Health San Antonio, San Antonio, TX
2MD Anderson Cancer Center, University of Texas, Houston, TX
3Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
4Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
5Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
6Miguel Servet University Hospital and Centro de Investigacion Biomedica en Red de Enfermadades Raras (CIBERER), Zaragoza, Spain
7Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, Paris, France
8Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
9Department of Hematology and Department of Microbiology and Immunology, University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium
10University of Insubria, Varese, Italy
11Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary
12University of Florence, Azienda Ospedaliero Universitaria Careggi, CRIMM, Florence, Italy
13Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów, Poland
14Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
15Sierra Oncology Inc., San Mateo, CA
16Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom